Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/AIM-IMMUNOTECH-INC-65218228/news/AIM-ImmunoTech-Announces-First-Subject-Dosed-in-the-Netherlands-for-Phase-1b-2-Study-Evaluating-Ampl-45960781/?utm_source=whatsapp&utm_medium=social&utm_campaign=share